Ontology highlight
ABSTRACT:
SUBMITTER: Heo H
PROVIDER: S-EPMC9440127 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
Heo Haejeong H Kim Jong-Hwan JH Lim Hyun Jung HJ Kim Jeong-Hwan JH Kim Miso M Koh Jaemoon J Im Joo-Young JY Kim Bo-Kyung BK Won Misun M Park Ji-Hwan JH Shin Yang-Ji YJ Yun Mi Ran MR Cho Byoung Chul BC Kim Yong Sung YS Kim Seon-Young SY Kim Mirang M
Experimental & molecular medicine 20220823 8
Acquired resistance to inhibitors of anaplastic lymphoma kinase (ALK) is a major clinical challenge for ALK fusion-positive non-small-cell lung cancer (NSCLC). In the absence of secondary ALK mutations, epigenetic reprogramming is one of the main mechanisms of drug resistance, as it leads to phenotype switching that occurs during the epithelial-to-mesenchymal transition (EMT). Although drug-induced epigenetic reprogramming is believed to alter the sensitivity of cancer cells to anticancer treatm ...[more]